We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MQG:ASXMacquarie Group, Ltd. Analysis

Data as of 2026-05-29 - not real-time

A$238.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Macquarie Group is trading at $238.55, essentially flat on its 20‑day SMA (238.53) and comfortably above the 50‑day (227.62) and 200‑day (215.34) averages, underscoring a bullish trend despite a bearish MACD histogram (-1.10) and a neutral RSI (54). The stock sits above its near‑term support at $230.44 with resistance near $249.49, while volatility remains elevated at ~23% over 30 days and beta is modest at 0.91, suggesting market‑aligned price swings.
Fundamentally, revenue grew 5.8% YoY and profit margins stay strong (operating 28.4%, net 21.1%). EPS is projected to rise from 9.71 to 12.28, pulling the forward P/E down to 19.4, yet the trailing P/E of 24.6 sits well above the industry average of 16.5, flagging potential overvaluation. The dividend yield of 3.43% is attractive but the payout ratio of 67% is backed by negative operating cash flow and a net cash deficit after debt, raising questions on sustainability. Recent material news – a 30% jump in FY profit and the strategic acquisition of a stake in New Zealand’s Contact Energy – adds earnings momentum and diversification, but the cash‑flow backdrop tempers optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price aligned with 20‑day SMA and above longer‑term averages
  • Bearish MACD histogram suggesting near‑term caution
  • Recent earnings beat and acquisition news supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E compression to 19.4 indicating improving valuation
  • 30% profit growth and diversification via Contact Energy stake
  • Attractive dividend yield despite cash‑flow concerns

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong brand and global capital‑markets franchise
  • Sustained dividend yield but cash‑flow and debt pressures
  • Valuation still above peers, requiring earnings expansion for upside

Key Metrics & Analysis

Financial Health

Revenue Growth5.80%
Profit Margin21.12%
P/E Ratio24.6
ROE11.21%
ROA0.85%
P/B Ratio2.5
Op. Cash FlowA$-31581999104
Industry P/E16.5

Technical Analysis

TrendBullish
RSI54.4
SupportA$230.44
ResistanceA$249.49
MA 20A$238.53
MA 50A$227.62
MA 200A$215.34
MACDBearish
VolumeIncreasing
Fear & Greed Index93.23

Valuation

Target PriceA$240.03
Upside/Downside0.62%
GradeOvervalued
TypeBlend
Dividend Yield3.43%

Risk Assessment

Beta0.91
Volatility23.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.